Acumen Pharmaceuticals, Inc. (ABOS)
3.18
+0.09
(+2.91%)
USD |
NASDAQ |
Sep 04, 16:00
3.17
-0.01
(-0.31%)
After-Hours: 20:00
Acumen Pharmaceuticals Shareholders Equity (Quarterly) : 57.26M for June 30, 2026
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 57.26M |
| March 31, 2026 | 87.48M |
| December 31, 2025 | 70.43M |
| September 30, 2025 | 93.17M |
| June 30, 2025 | 117.08M |
| March 31, 2025 | 155.52M |
| December 31, 2024 | 181.82M |
| September 30, 2024 | 217.20M |
| June 30, 2024 | 243.95M |
| March 31, 2024 | 262.03M |
| December 31, 2023 | 266.97M |
| September 30, 2023 | 280.27M |
| Date | Value |
|---|---|
| June 30, 2023 | 168.87M |
| March 31, 2023 | 179.08M |
| December 31, 2022 | 188.78M |
| September 30, 2022 | 196.65M |
| June 30, 2022 | 206.52M |
| March 31, 2022 | 216.09M |
| December 31, 2021 | 225.18M |
| September 30, 2021 | 233.36M |
| June 30, 2021 | 68.42M |
| March 31, 2021 | 11.19M |
| December 31, 2020 | 38.06M |
Shareholders' Equity Definition
Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Biogen, Inc. | 18.85B |
| ACADIA Pharmaceuticals, Inc. | 1.307B |
| Alnylam Pharmaceuticals, Inc. | 1.354B |
| Anika Therapeutics, Inc. | 137.28M |
| Savara, Inc. | 143.66M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 116.01M |
| Total Liabilities (Quarterly) | 58.74M |
| Debt to Equity Ratio | 0.5526 |
| Current Ratio | 2.466 |
| Net Debt Paydown Yield | -0.19% |